Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, signaling a minor patch or update to the page or its underlying tooling. This update does not change the study details or visible content.SummaryDifference0.0%

- Check15 days agoChange DetectedThe 'Other Study ID Numbers' section now includes '2015 ( U.S. NIH Grant/Contract )', indicating NIH funding for the study. This addition provides context about the funding source associated with the trial.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe revision history now shows a new version v3.6.5, replacing v3.6.4. This reflects an update to the page's documentation/versioning rather than substantive content changes.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page's revision tag was updated to v3.6.4, replacing the previous v3.6.3 as part of an internal revision history update.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.0, indicating an updated internal build of the study details page.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now displays that recruitment is closed with a 'No longer looking for participants' notice. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a minor formatting change was made to the Interventions label (Intervention / Treatment → Intervention/Treatment) along with a revision version update from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.